Grand View Research, Incの新刊レポートによると、世界のハンチントン病治療の市場規模は2030年までに18億ドルに達し、2022年から2030年までのCAGRは19.6％と予想されます。この成長を促す要因は、新製品の開発や共同研究のための高額な研究開発投資、および西側諸国における高いHD負担です。ハンチントン病は、数世代に影響を与える希少な遺伝性神経変性疾患です。それは30歳から50歳までの人々に影響を及ぼし、働く能力、家族の世話、そして最終的には日常の仕事を完了する能力を損ないます。
有病率は地域によって10倍以上異なります。これは、症例確認と診断基準の違いに関連している可能性があります。結果として、一般集団におけるenlarged repetitions の有病率は予想以上に大きい可能性があります。アジアの人口は一貫して低い有病率でしたが、ヨーロッパ、北アメリカ、オーストラリアは高い有病率です。
目次
Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 Huntington’s Disease Treatment Market Variables, Trends, and Scope
3.1 Parent Market Outlook
3.1.1 Central Nervous System Therapeutics Market
3.2 Penetration and Growth Prospect Mapping
3.3 Regulatory & Reimbursement Scenario
3.4 Market Driver Analysis
3.4.1 Strong Product Pipeline
3.4.2 Disease Burden Of Huntington’s In Developed Countries
3.5 Market Restraint Analysis
3.5.1 Significant Challenges And Unmet Needs In Huntington’s Disease Treatment
3.5.2 High Failure Rate In Clinical Trials
3.6 Major Deals and Strategic Alliances
3.7 Pipeline Analysis
3.8 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.9 Industry Analysis - Porter’s
Chapter 4 Huntington’s Disease Treatment Market: Competitive Analysis
4.1 Recent Developments and Impact Analysis, by Key Market Participants
4.1.1 New Product Launches
4.1.2 Mergers And Acquisitions
4.1.3 Partnerships And Strategic Collaboration
4.1.4 Conferences And Campaigns
4.2 Company Categorization
4.2.1 Innovators
4.2.2 Market Leaders
4.2.3 Heat Map Analysis
4.3 Vendor Landscape
4.3.1 List Of Key Distributors And Channel Partners
4.3.2 Key Customers
4.4 Key Company Market Share Analysis, 2021
4.5 Public Companies
4.5.1 Company Market Position Analysis
4.5.2 Competitive Dashboard Analysis
4.5.2.1 Market Differentiators
4.6 Private Companies
4.6.1 List Of Key Emerging Companies
4.6.2 Regional Network Map
Chapter 5 Huntington’s Disease Treatment Market: Segment Analysis, by Treatment, 2017 - 2030 (USD Million)
5.1 Huntington’s Disease Treatment Market: Treatment Movement Analysis
5.2 Symptomatic Treatment
5.2.1 Symptomatic Treatment Market, 2017 - 2030 (USD Million)
5.3 Disease-Modifying Therapies
5.3.1 Disease-Modifying Therapies Market, 2017 - 2030 (USD Million)
Chapter 6 Huntington’s Disease Treatment Market: Segment Analysis, By Region, 2017 - 2030 (USD Million)
6.1 Definition & Scope
6.2 Regional Market Share Analysis, 2021 & 2030
6.3 Regional Market Snapshot
6.4 Market Size, & Forecasts, Revenue and Trend Analysis, 2021 to 2030
6.4.1 North America
6.4.1.1 North America market estimates and forecast, 2017 - 2028 (USD Million)
6.4.1.2 U.S.
6.4.1.2.1 U.S. Huntington’s Disease Treatment market, 2017 - 2030 (USD Million)
6.4.1.3 Canada
6.4.1.3.1 Canada Huntington’s Disease Treatment market, 2017 - 2030 (USD Million)
6.4.2 Europe
6.4.2.1 Europe Huntington’s Disease Treatment market, 2017 - 2030 (USD Million)
6.4.2.2 U.K.
6.4.2.2.1 U.K. Huntington’s Disease Treatment market, 2017 - 2030 (USD Million)
6.4.2.3 Germany
6.4.2.3.1 Germany Huntington’s Disease Treatment market, 2017 - 2030 (USD Million)
6.4.2.4 Spain
6.4.2.4.1 Spain Huntington’s Disease Treatment market, 2017 - 2030 (USD Million)
6.4.2.5 France
6.4.2.5.1 France Huntington’s Disease Treatment market, 2017 - 2030 (USD Million)
6.4.2.6 Italy
6.4.2.6.1 Italy Huntington’s Disease Treatment market, 2017 - 2030 (USD Million)
6.4.3 Asia Pacific
6.4.3.1 Asia Pacific Huntington’s Disease Treatment market, 2017 - 2030 (USD Million)
6.4.3.2 Japan
6.4.3.2.1 Japan Huntington’s Disease Treatment market, 2017 - 2030 (USD Million)
6.4.3.3 China
6.4.3.3.1 China Huntington’s Disease Treatment market, 2017 - 2030 (USD Million)
6.4.3.4 India
6.4.3.4.1 India Huntington’s Disease Treatment market, 2017 - 2030 (USD Million)
6.4.3.5 South Korea
6.4.3.5.1 South Korea Huntington’s Disease Treatment market, 2017 - 2030 (USD Million)
6.4.3.6 Australia
6.4.3.6.1 Australia Huntington’s Disease Treatment market, 2017 - 2030 (USD Million)
6.4.4 Latin America
6.4.4.1 Latin America Huntington’s Disease Treatment market, 2017 - 2030 (USD Million)
6.4.4.2 Brazil
6.4.4.2.1 Brazil Huntington’s Disease Treatment market, 2017 - 2030 (USD Million)
6.4.4.3 Mexico
6.4.4.3.1 Mexico Huntington’s Disease Treatment market, 2017 - 2030 (USD Million)
6.4.4.4 Argentina
6.4.4.4.1 Argentina Huntington’s Disease Treatment market, 2017 - 2030 (USD Million)
6.4.5 MEA
6.4.5.1 MEA Huntington’s Disease Treatment market, 2017 - 2030 (USD Million)
6.4.5.2 South Africa
6.4.5.2.1 South Africa Huntington’s Disease Treatment market, 2017 - 2030 (USD Million)
6.4.5.3 Saudi Arabia
6.4.5.3.1 Saudi Arabia Huntington’s Disease Treatment market, 2017 - 2030 (USD Million)
6.4.5.4 UAE
6.4.5.4.1 UAE Huntington’s Disease Treatment market, 2017 - 2030 (USD Million)
Chapter 7 Huntington’s Disease Treatment Market: Company Profiles
7.1 H. Lundbeck A/S
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Product Benchmarking
7.1.4 Strategic Initiatives
7.2 Teva Pharmaceutical Industries Ltd.
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Product Benchmarking
7.2.4 Strategic Initiatives
7.3 Bausch Health Companies Inc.
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Product Benchmarking
7.3.4 Strategic Initiatives
7.4 Hetero
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Product Benchmarking
7.4.4 Strategic Initiatives
7.5 Lupin
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Product Benchmarking
7.5.4 Strategic Initiatives
7.6 Hikma Pharmaceuticals PLC
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Product Benchmarking
7.6.4 Strategic Initiatives
7.7 Dr. Reddy’s Laboratories Ltd.
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Product Benchmarking
7.7.4 Strategic Initiatives
7.8 Sun Pharmaceutical Industries Ltd.
7.8.1 Company Overview
7.8.2 Financial Performance
7.8.3 Product Benchmarking
7.8.4 Strategic Initiatives
List of Tables
TABLE 1 List of secondary sources
TABLE 2 List of Abbreviations
TABLE 3 North America Huntington’s Disease Treatment market estimates and forecasts, by country, 2017 - 2030 (USD Million)
TABLE 4 North America Huntington’s Disease Treatment market estimates and forecasts, by treatment, 2017 - 2030 (USD Million)
TABLE 5 U.S. Huntington’s Disease Treatment market estimates and forecasts, by treatment, 2017 - 2030 (USD Million)
TABLE 6 Canada Huntington’s Disease Treatment market estimates and forecasts, by treatment, 2017 - 2030 (USD Million)
TABLE 7 Europe Huntington’s Disease Treatment market estimates and forecasts, by country, 2017 - 2030 (USD Million)
TABLE 8 Europe Huntington’s Disease Treatment market estimates and forecasts, by treatment, 2017 - 2030 (USD Million)
TABLE 9 U.K. Huntington’s Disease Treatment market estimates and forecasts, by treatment, 2017 - 62028 (USD Million)
TABLE 10 Germany Huntington’s Disease Treatment market estimates and forecasts, by treatment, 2017 - 2030 (USD Million)
TABLE 11 France Huntington’s Disease Treatment market estimates and forecasts, by treatment, 2017 - 2030 (USD Million)
TABLE 12 Italy Huntington’s Disease Treatment market estimates and forecasts, by treatment, 2017 - 2030 (USD Million)
TABLE 13 Spain Huntington’s Disease Treatment market estimates and forecasts, by treatment, 2017 - 2030 (USD Million)
TABLE 14 Asia Pacific Huntington’s Disease Treatment market estimates and forecasts, by country, 2017 - 2030 (USD Million)
TABLE 15 Asia Pacific Huntington’s Disease Treatment market estimates and forecasts, by treatment, 2017 - 2030 (USD Million)
TABLE 16 Japan Huntington’s Disease Treatment market estimates and forecasts, by treatment, 2017 - 2030 (USD Million)
TABLE 17 China Huntington’s Disease Treatment market estimates and forecasts, by treatment, 2017 - 2030 (USD Million)
TABLE 18 India Huntington’s Disease Treatment market estimates and forecasts, by treatment, 2017 - 2030 (USD Million)
TABLE 19 Australia Huntington’s Disease Treatment market estimates and forecasts, by treatment, 2017 - 2030 (USD Million)
TABLE 20 South Korea Huntington’s Disease Treatment market estimates and forecasts, by treatment, 2017 - 2030 (USD Million)
TABLE 21 Latin America Huntington’s Disease Treatment market estimates and forecasts, by country, 2017 - 2030 (USD Million)
TABLE 22 Latin America Huntington’s Disease Treatment market estimates and forecasts, by treatment, 2017 - 2030 (USD Million)
TABLE 23 Brazil Huntington’s Disease Treatment market estimates and forecasts, by treatment, 2017 - 2030 (USD Million)
TABLE 24 Mexico Huntington’s Disease Treatment market estimates and forecasts, by treatment, 2017 - 2030 (USD Million)
TABLE 25 Argentina Huntington’s Disease Treatment market estimates and forecasts, by treatment, 2017 - 2030 (USD Million)
TABLE 26 MEA Huntington’s Disease Treatment market estimates and forecasts, by country, 2017 - 2030 (USD Million)
TABLE 27 MEA Huntington’s Disease Treatment market estimates and forecasts, by treatment, 2017 - 2030 (USD Million)
TABLE 28 South Africa Huntington’s Disease Treatment market estimates and forecasts, by treatment, 2017 - 2030 (USD Million)
TABLE 30 Saudi Arabia Huntington’s Disease Treatment market estimates and forecasts, by treatment, 2017 - 2030 (USD Million)
TABLE 31 UAE Huntington’s Disease Treatment market estimates and forecasts, by treatment, 2017 - 2030 (USD Million)
TABLE 32 List of key distributors
List of Figures
FIG. 1 Huntington’s disease treatment market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value-chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 Market outlook (2021)
FIG. 10 Penetration and growth prospect mapping
FIG. 11 Huntington’s disease treatment market driver impact
FIG. 12 Huntington’s disease treatment market restraint impact
FIG. 13 Major deals and strategic alliances
FIG. 14 SWOT analysis, by factor (political & legal, economic, and technological)
FIG. 15 Porter’s five forces analysis
FIG. 16 Heat map analysis
FIG. 17 Company market position analysis (2021)
FIG. 18 Company market position analysis (2021)
FIG. 19 Company market position analysis (2021)
FIG. 20 Market differentiators
FIG. 21 Regional network map
FIG. 22 Huntington’s disease treatment market treatment outlook: Key takeaways
FIG. 23 Huntington’s disease treatment market: Treatment movement analysis
FIG. 24 Symptomatic treatment market, 2017 - 2030 (USD million)
FIG. 25 Disease-modifying therapies market, 2017 - 2030 (USD million)
FIG. 26 Regional outlook, 2021& 2030
FIG. 27 Regional marketplace: Key takeaways
FIG. 28 North America
FIG. 29 North America Huntington’s disease treatment market, 2017 - 2030 (USD Million)
FIG. 30 U.S.
FIG. 31 U.S. Huntington’s disease treatment market, 2017 - 2030 (USD Million)
FIG. 32 Canada
FIG. 33 Canada Huntington’s disease treatment market, 2017 - 2030 (USD Million)
FIG. 34 Europe
FIG. 35 Europe Huntington’s disease treatment market, 2017 - 2030 (USD Million)
FIG. 36 U.K.
FIG. 37 U.K. Huntington’s disease treatment market, 2017 - 2030 (USD Million)
FIG. 38 Germany
FIG. 39 Germany Huntington’s disease treatment market, 2017 - 2030 (USD Million)
FIG. 40 Spain
FIG. 41 Spain Huntington’s disease treatment market, 2017 - 2030 (USD Million)
FIG. 42 France
FIG. 43 France Huntington’s disease treatment market, 2017 - 2030 (USD Million)
FIG. 44 Italy
FIG. 45 Italy Huntington’s disease treatment market, 2017 - 2030 (USD Million)
FIG. 46 Asia Pacific
FIG. 47 Asia Pacific Huntington’s disease treatment market, 2017 - 2030 (USD Million)
FIG. 48 Japan
FIG. 49 Japan Huntington’s disease treatment market, 2017 - 2030 (USD Million)
FIG. 50 China
FIG. 51 China Huntington’s disease treatment market, 2017 - 2030 (USD Million)
FIG. 52 India
FIG. 53 India Huntington’s disease treatment market, 2017 - 2030 (USD Million)
FIG. 54 South Korea
FIG. 55 South Korea Huntington’s disease treatment market, 2017 - 2030 (USD Million)
FIG. 56 Australia
FIG. 57 Australia Huntington’s disease treatment market, 2017 - 2030 (USD Million)
FIG. 58 Latin America
FIG. 59 Latin America Huntington’s disease treatment market, 2017 - 2030 (USD Million)
FIG. 60 Brazil
FIG. 61 Brazil Huntington’s disease treatment market, 2017 - 2030 (USD Million)
FIG. 62 Mexico
FIG. 63 Mexico Huntington’s disease treatment market, 2017 - 2030 (USD Million)
FIG. 64 Argentina
FIG. 65 Argentina Huntington’s disease treatment market, 2017 - 2030 (USD Million)
FIG. 66 Middle East and Africa
FIG. 67 MEA Huntington’s disease treatment market, 2017 - 2030 (USD Million)
FIG. 68 South Africa
FIG. 69 South Africa Huntington’s disease treatment market, 2017 - 2030 (USD Million)
FIG. 70 Saudi Arabia
FIG. 71 Saudi Arabia Huntington’s disease treatment market, 2017 - 2030 (USD Million)
FIG. 72 UAE
FIG. 73 UAE Huntington’s disease treatment market, 2017 - 2030 (USD Million)
